Expect an improving trend after a weak 1Q24
China Policy – Credit growth is expected to rebound in 2023
Expect strong growth to continue after the impressive 1H23; U/G to BUY
Growth beat expectations with recovery underway
CMS Strategy Weekly: Rate expectations see upward revision
Weak 1Q23 as expected; Expect multiple drivers from iPhone/CPU socket/400G/EV in 2H23E
3Q24 earnings below expectations due to margin contraction
Is High Debt Constraining Monetary Policy? Evidence from Inflation Expectations
Expect strong sales in 2023 driven by the US approval of zanubrutinib in CLL
Net profit +3.5x YoY in 2022 but below expectations; Attractive yield of 20%